Article
Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges
14 Feb 2022
Abstract excerpt
Cancer is considered by not only multiple genetic but also epigenetic amendments that drive malignant cell propagation and consult chemo-resistance. The ability to correct or ablate such mutations holds enormous promise for battling cancer. Recently, because of its great efficiency and feasibility, the CRISPR-Cas9 advanced genome editing technique has been extensively considered for therapeutic investigations of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
